The role of mepolizumab in atopic and nonatopic severe asthma with persistent eosinophilia
Open Access
- 23 March 2014
- journal article
- Published by European Respiratory Society (ERS) in European Respiratory Journal
- Vol. 44 (1) , 239-241
Abstract
No abstract availableThis publication has 14 references indexed in Scilit:
- International ERS/ATS guidelines on definition, evaluation and treatment of severe asthmaEuropean Respiratory Journal, 2013
- Identification of asthma clusters in two independent Korean adult asthma cohortsEuropean Respiratory Journal, 2012
- Mepolizumab for severe eosinophilic asthma (DREAM): a multicentre, double-blind, placebo-controlled trialThe Lancet, 2012
- The who, where, and when of IgE in allergic airway diseaseJournal of Allergy and Clinical Immunology, 2012
- Randomized Trial of Omalizumab (Anti-IgE) for Asthma in Inner-City ChildrenNew England Journal of Medicine, 2011
- Identification of Asthma Phenotypes Using Cluster Analysis in the Severe Asthma Research ProgramAmerican Journal of Respiratory and Critical Care Medicine, 2010
- Epidemiology of asthma exacerbationsJournal of Allergy and Clinical Immunology, 2008
- Experimental rhinovirus challenges in adults with mild asthma: Response to infection in relation to IgEJournal of Allergy and Clinical Immunology, 2003
- Local expression of ϵ germline gene transcripts and RNA for the ϵ heavy chain of IgE in the bronchial mucosa in atopic and nonatopic asthmaJournal of Allergy and Clinical Immunology, 2001
- IL-4 and IL-5 mRNA and Protein in Bronchial Biopsies From Patients With Atopic and Nonatopic Asthma: Evidence Against "Intrinsic" Asthma Being a Distinct Immunopathologic EntityAmerican Journal of Respiratory and Critical Care Medicine, 1996